Breaks Categories: News

WednesdayFeb 28, 2024 12:04 pm

NetworkNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports on Year-End 2023 Financial Results, Corporate Update

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has released a financial report for the year ended Dec. 31, 2023; the report also included a corporate update. The report noted that revenues for 2023 totaled $0.7 million with grant revenue for 2023 being less than $0.1 million; related cost of revenues was $0.5 million for 2023; and gross profit for the year came in at approximately $0.2 million. In addition, general and administrative expenses totaled $11.4 million for 2023; research and development expenses decreased to approximately $9.1 million with selling and marketing expenses for…

Continue Reading

WednesdayFeb 28, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces Completion Clinical Stage of Phase 1 Trial, Featured in Proactive Video Releases

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has completed the clinical stage of its phase 1 single ascending dose escalation trial, designed to evaluate TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb) in healthy volunteers. According to the announcement, the company anticipates receiving topline results from the trial in Q3 2024 and is now planning a phase 2 trial focused on evaluating the drug for prevention of kidney transplant rejection. In addition, Tonix Pharmaceuticals CEO Seth Lederman, MD, was featured in two releases from Proactive, a best-in-class media provider of 24/7…

Continue Reading

TuesdayFeb 27, 2024 2:43 pm

NetworkNewsBreaks – DealFlow Events Announces IBN to Return as Official Media Partner for Upcoming Activist Investor Conference

DealFlow Events, host of hundreds of conferences over the past two decades, has selected IBN as the official media partner for the upcoming Activist Investor Conference 2024. DealFlow Events is organizing and hosting the event, which is slated for March 21, 2024, in New York City. Focused on the industry’s most innovative and transformative ideas, the conference has been around for more than a decade and is designed to provide invaluable opportunities for professional education and networking as well as forging new business relationships. Information presented during the event is designed to support investors as they work on deepening their…

Continue Reading

TuesdayFeb 27, 2024 12:55 pm

NetworkNewsBreaks – RB Capital Partners Inc. Moves Forward with Appointment of Receiver for Optec International Inc. (OPTI)

RB Capital Partners, a judgment creditor against Optec International Inc. (OTC: OPTI), today announced its engagement of Mark Basile and The Basile Law Firm P.C. to work with the courts to officially appoint a receiver to run Optec in the interim while a new company is merged into the public vehicle. RB Capital, the largest investor and legitimate shareholder of Optec International, was forced to bring a shareholder derivative action against Optec to secure the company’s judgment, oust Roger Pawson and to try to preserve Optec’s assets. According to the announcement, the next step in the process is to officially…

Continue Reading

TuesdayFeb 27, 2024 12:53 pm

NetworkNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured as ‘Beacon of Innovation’ in Corporate Investment Times

Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens, was featured in the most recent edition of the Corporate Investment Times. The article, titled “Pioneering the Future of Digital Assets and Security Tokens,” discusses a profound transformation in the financial world driven by the emergence of tokenization. In this new realm, “visionaries such as Larry Fink of BlackRock and Jonathan Larsen of Ping A Global Voyager Fund foresee a future where digital assets traded on innovative protocols revolutionize transactions… where settlements occur instantaneously, and fees plummet,…

Continue Reading

TuesdayFeb 27, 2024 12:15 pm

NetworkNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App to Help Manage Transportation Needs for Envases Universales

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company whose custom-developed, industry leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, today announced a significant collaboration with Envases Universales, one of the largest packaging companies worldwide. According to the announcement, Fr8App was awarded key routes through Envases’ annual 2024 RFQ, underscoring its commitment to delivering exceptional transportation services and its capability to meet the evolving needs of its clients. “We are thrilled to have been chosen by Envases Universales to help manage their transportation needs over the coming year,” said Fr8App’s CEO…

Continue Reading

TuesdayFeb 27, 2024 12:02 pm

NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with TráTek Monitoring Services, Expands Services in Canada

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, is partnering with TráTek Monitoring Services to expand its footprint in Canada. The company announced that TráTek, which is based in British Columbia, has signed an agreement to adopt its SOBRsafe technology for use in its family law practice with voluntary pretrial clients. In conjunction with the agreement, TráTek has purchased multiple SOBRcheck(TM) and SOBRsure(TM) devices. TráTek has become a licensed channel partner of alcohol monitoring technologies and works to support the legal system across Canada. According to the announcement, the company plans to deploy SOBRsafe solutions nationwide through its regional…

Continue Reading

TuesdayFeb 27, 2024 8:30 am

NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Releases Positive Results from PK Bridging Study, Anticipates Development in Japan and China

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is reporting positive results from its clinical pharmacokinetic (“PK”) bridging study of Tonmya(TM). The study evaluated the efficacy of Tonmya, also known as TNX-102 SL (cyclobenzaprine HCl sublingual tablets), in healthy adult male and female ethnic Japanese and Chinese volunteers. The report noted that Tonmya was generally well tolerated in the ethnic Japanese and Chinese healthy volunteers. Tonix holds issued patents for market exclusivity rights of Tonmya in Japan, China, Hong Kong and Taiwan.” “This bridging study is an important first step as we…

Continue Reading

MondayFeb 26, 2024 2:10 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases Update Strategic Focus on Commercial Vehicle Segment

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting on its continued focus on the commercial vehicle segment with production and deliveries of its Class 1 and Class 3 commercial EVs. According to the announcement, the company is in full commercial production of the Class 1 and Class 3 EV vehicles while subsidiary Bollinger Motors is focused on Class 4–6 vehicles; production of the Class 4 EV is set to begin in the second half of 2024. In addition, Mullen saw positive gross margin per Class 1 and Class 3 vehicles invoiced. The company also noted that…

Continue Reading

MondayFeb 26, 2024 1:56 pm

NetworkNewsBreaks – Vocodia Holdings Corp. (CBOE: VHAI) Announces $5.95M IPO

Vocodia Holdings Corp. (CBOE: VHAI, VHAI+A, VHAI+B), a software company that builds practical AI functions, recently announced the pricing of its underwritten initial public offering of 1,400,000 units, each consisting of one share of common stock of the company, par value $0.0001 (“Common Stock”), one Series A Warrant to purchase one share of Common Stock at $4.25 (the “Series A Warrant”), and one Series B Warrant to purchase one share of Common Stock at $8.50 (the “Series B Warrant”), at a price to the public of $4.25 per unit. Gross proceeds from the offering were expected to be approximately $5,950,000.…

Continue Reading